| abstract |
The present invention includes at least one pharmaceutically active ingredient and the following compound 1,4 O-linked D-gal-saccharose (lactosucrose), 1,4 O-linked D-glu-saccharose (glucosyl sucrose) or 1 , 4 O-linked glu-glu-saccharose (maltosyl sucrose), a powder comprising at least one 1,4 O-linked saccharose derivative combined with at least one additional adjuvant About. The additional adjuvant is preferably an amino acid, a peptide and / or a monosaccharide, disaccharide and / or oligosaccharide. In the case of an oligosaccharide, if it is different from the first saccharose derivative, the second 1,4 O-linked type It may be a saccharose derivative. |